Clinical Cell and Vaccine Production Facility (CVPF)
The Clinical Cell and Vaccine Production Facility (CVPF) renders bench-to-bedside translational medicine a reality. Equipped with state of the art facilities, the CVPF manufactures cell and gene biotherapeutics and has been accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) since 2008. As a shared resource within the Center for Cellular Immunotherapies (CCI) and the Division of Transfusion Medicine & Therapeutic Pathology within the Department of Pathology & Laboratory Medicine, the CVPF supports numerous investigational new drug (IND) protocols. Current protocols target a variety of disease indications (primarily HIV, adult and pediatric cancers, and stroke); many more trials are in development and, once approved, will further expand the scope of diseases targeted for cell and gene therapy. For more information on current trials, see our Clinical Trials page.
Recent News & Highlights
Crispr Takes Its First Steps in Editing Genes to Fight Cancer
Nov. 06, 2019
Doctors have for the first time in the United States tested a powerful gene-editing technique in people with cancer.
Translating Scientific and Technology Innovations from Academic Centres of Excellence to Industry
Aug 01, 2019
Phacilitate Interview with Dr. Bruce Levine
Recent & Upcoming Events
2021 Breakthrough Bike Challenge
Sunday, September 12,2021
100% of participant-raised funds go to support Penn Medicine's Abramson Cancer Center. Your participation fuels the research that will deliver breakthroughs!